News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Recipharm AB: Interim Report January – March 2014
May 12, 2014
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Regulatory News:
Recipharm AB (STO:RECI):
· Net sales amounted to SEK 578 million (517) an increase of 11,7 % (9,4% in constant FX-rates)
Help employers find you! Check out all the
jobs
and
post your resume
.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Business
Novo Breaks $598M Heartseed Pact Amid ‘Decisive Restructuring’ by New CEO
October 1, 2025
·
2 min read
·
Tristan Manalac
Opinion
The Urgent Need To Redefine the Future of UK Biotech
October 1, 2025
·
6 min read
·
Kerstin Papenfuss
Layoffs
Sutro Makes Deeper Cuts To Extend Runway Into 2027, Reach Key Data Readout
September 30, 2025
·
1 min read
·
Dan Samorodnitsky
Series A
Novo-Backed Crystalys Debuts With $205M to Tackle Gout
September 30, 2025
·
2 min read
·
Tristan Manalac